JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,454 | -97.5% | 10,319 | -94.7% | 0.00% | – |
| Q3 2022 | $452,000 | -21.5% | 193,496 | +1.7% | 0.00% | – |
| Q2 2022 | $576,000 | +689.0% | 190,173 | +1666.3% | 0.00% | – |
| Q1 2022 | $73,000 | -15.1% | 10,767 | +5.7% | 0.00% | – |
| Q4 2021 | $86,000 | -7.5% | 10,188 | -18.6% | 0.00% | – |
| Q3 2021 | $93,000 | +22.4% | 12,518 | +12.3% | 0.00% | – |
| Q2 2021 | $76,000 | -14.6% | 11,148 | -12.9% | 0.00% | – |
| Q4 2020 | $89,000 | -87.7% | 12,792 | -85.6% | 0.00% | – |
| Q3 2020 | $726,000 | -54.3% | 88,912 | -61.4% | 0.00% | -100.0% |
| Q2 2020 | $1,589,000 | +55.3% | 230,292 | +96.5% | 0.00% | – |
| Q4 2019 | $1,023,000 | – | 117,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
| TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
| Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
| Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
| Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
| ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
| Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
| Granahan Investment Management | 125,533 | $778,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
| Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |